Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Weight Loss 1Obesity 1Intermittent Fasting 1Colorectal Neoplasms 1

Interventions

Specimen Handling 267Magnetic Resonance Spectroscopy 218pembrolizumab 203Carboplatin 170Cisplatin 137Biopsy 136Cyclophosphamide 131Paclitaxel 120Nivolumab 110Bevacizumab 104Gemcitabine 102Radiotherapy 85Dexamethasone 77Pemetrexed 75atezolizumab 73Fluorouracil 71fludarabine 69Doxorubicin 68Leucovorin 66Docetaxel 66Radiation 65Oxaliplatin 62Rituximab 60venetoclax 58Prednisone 58Cetuximab 54durvalumab 53Vincristine 52Etoposide 51130-nm albumin-bound paclitaxel 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Caloric Restriction × 30 days × Clear all
NCT05114798 2026-05-22

Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers

University of Illinois at Chicago

Phase NA Active not recruiting
193 enrolled
GastrointestinalOther

Intermittent Fasting, Obesity, Colorectal Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡